Dec 23, 2020
Dr. Ragen discusses X4 Pharmaceuticals, which is currently developing therapies for rare genetic diseases that result from dysfunction of the immune system and is currently undergoing a global Phase 3 trial for WHIM Syndrome and two Phase 1b trials for Waldenstrom macroglobulinemia (WM), a type of rare lymphoma,...
Dec 16, 2020
We sit down with Dr. CJ Barnum, Director of Neuroscience at Inmune Bio, Inc. to talk about the recently announced grant from the NIH for $2.9 million to test a new hypothesis that #neuroinflammation plays a major role in treatment resistant depression (TRD).
This money will support a first-of-its-kind phase 2 study...
Dec 9, 2020
Hartmut Ehrlich and Philippe Pouletty discuss Abivax Pipeline of
Clinical Programs involving Covid-19, Ulcerative Colitis, Crohn's
Disease and more.
Ongoing Phase 2b/3 trial with ABX464 in Covid-19 (miR-AGE trial), the...
Dec 2, 2020
Dr. Negin Hajizadeh discussing Feinstein Institutes researchers finding an effective COVID-19 ‘cytokine storm’ treatment and more. Dr. Hajizadeh is an ICU pulmonologist and was a part of Northwell Health's, NY largest health system, at the height of the surge. She has experienced and delivered care first hand. She...